National Health Investors (NHI) Non Operating Interest Expenses (2011 - 2026)

National Health Investors (NHI) has reported Non Operating Interest Expenses for 16 consecutive years, with $15.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non Operating Interest Expenses rose 5.42% year-over-year to $15.8 million; the trailing twelve-month figure through Jun 2026 stood at $58.9 million (down 1.06% YoY), and the FY2025 full-year result was $57.4 million, down 4.23% from the prior year.
• Non Operating Interest Expenses improved to $15.8 million in Q2 2026 per NHI's latest filing, from $15.0 million in the prior quarter.
• Across five years, Non Operating Interest Expenses topped out at $15.8 million in Q2 2026 and bottomed at $10.2 million in Q1 2022.
• Historically, Non Operating Interest Expenses has averaged $14.0 million across 5 years, with a median of $14.6 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses slipped 21.39% in 2022, then surged 37.55% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $12.4 million in 2022, then increased by 19.34% to $14.9 million in 2023, then rose by 2.61% to $15.2 million in 2024, then retreated by 6.4% to $14.3 million in 2025, then grew by 10.87% to $15.8 million in 2026.
• According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $15.8 million, $15.0 million, and $14.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.